University of Dundee Study Suggests Meformin Reduces Risk of Cardiovascular Disease

Cardiovascular Disease

Nursing Times reports The University of Dundee study, the MET-REMODEL trial, found that the drug used to treat type 2 diabetes for the last 60 years reduced left ventricular hypertrophy (LVH) in patients with pre-diabetes and pre-existing heart disease.  They found the commonly used diabetes drug metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease according to the UK researchers. The findings were reported in the European Heart Journal.

Lead Research/Investigator

Professor Chim Lang